American Diabetes Association’s 85th Scientific Sessions Recap

In late June, Glooko was proud to participate in the American Diabetes Association’s 85th Scientific Sessions in Chicago. We had the opportunity to connect with healthcare professionals, device partners, and diabetes community leaders to advance our digital health platform as we continue to power smarter, more efficient diabetes care.

From demonstrating our best-in-class EHR integrations that help simplify clinical workflows to sharing how our connected care solution integrates with more than 200 diabetes and health monitoring devices to drive more informed insights and better health outcomes, our presence at American Diabetes Association’s 85th Scientific Sessions was all about innovation and collaboration.

We were especially excited to host attendees at our Product Theater, where Glooko clinical experts Mark Clements, M.D., Ph.D., and Trisha Martinez, M.B.A., B.S.N., R.N., highlighted the impact of Glooko’s seamless EHR integration assets, tools, and capabilities that help streamline workflows, deliver actionable insights, and better manage patient populations with diabetes. Attendees also received early access to the 2025 Glooko Global Diabetes Report, which features a comprehensive look at how real-world data can drive better outcomes in diabetes care and help shape a smarter, more connected future of diabetes management.

Key ADA 2025 Takeaways from Team Glooko

	Mike Alvarez, CEO, Glooko: “The energy at ADA this year was incredible. I think this clearly signals how fast-moving innovation is in diabetes care. We had so many great conversations with clinicians and partners energized by what Glooko is bringing to the table — and we’re just getting started.”
	Rich Glenn, President, Connected Care, Glooko: “Participating in the ADA’s 85th Scientific Sessions reaffirmed the critical role Glooko plays in advancing connected care. Engaging with healthcare leaders, partners, and innovators gave us valuable insights to continue evolving our platform and ensuring we remain at the forefront of delivering smarter, more efficient diabetes management tools for healthcare providers and people living with diabetes.”
	Trisha Martinez, Senior Director, Clinical Transformation, Glooko: “The event reinforced the importance of data architecture that supports enterprise-level clinical reporting and delivers segmented insights to large health systems. CGMs continue to show promise, and there’s exciting potential for similar innovations in kidney and liver testing that could be tied to outcomes, population health, and prevention of chronic complications. Outpatient tech is evolving, potentially strengthening ties to hospital services. It’s also clear that demonstrating outcomes and integrating more services into the Glooko platform is key to enabling comprehensive disease management.”
	Rachel Beecham, Regional Vice President, Connected Care, South Central, Glooko: “Having the opportunity to spend time with people living with diabetes and their caregivers provided a meaningful perspective on the daily challenges they face and the care they require — deepening my sense of purpose and strengthening the mission behind our work at Glooko.”
	Adam Greenwald, Senior Customer Success Manager, Southwest, Glooko: “As a longtime Glooko employee, the annual American Diabetes Association event enabled me to continue to deepen my diabetes industry knowledge by exploring new cutting-edge diabetes technologies and strengthening connections with my peers, thought leaders, and customers.”

What’s Next? Connect with Team Glooko

Interested in learning more about what Glooko’s diabetes management platform has to offer your hospital, health system, or clinic? Schedule a personalized demo.

This is not part of the 85th Scientific Sessions as planned by the American Diabetes Association®. This content is neither sponsored nor endorsed by the American Diabetes Association®. This content does not qualify for continuing medical education (CME) credit.